Method for the prevention and treatment of cancer by inhibition of GPVI

Details for Australian Patent Application No. 2009240269 (hide)

Owner CSL Behring GmbH

Inventors Kronthaler, Ulrich; Nieswandt, Bernhard

Agent Watermark

Pub. Number AU-A-2009240269

PCT Pub. Number WO2009/129980

Priority 08007754.8 22.04.08 EP

Filing date 20 April 2009

Wipo publication date 29 October 2009

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

18 November 2010 PCT application entered the National Phase

  PCT publication WO2009/129980 Priority application(s): WO2009/129980

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009240274-Aqueous dispersion of fructan-containing particles, method of preparation and use

2009240266-Process and plant for the heat treatment of fine-grained mineral solids